Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Stek

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 23, 2022
Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026sKristina M Brooks, Mauricio Pinilla, Alice M Stek, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 24, 2004
Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022Jane Hitti, Lisa M Frenkel, Alice M Stek, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 26, 2019
Predictors of Viremia in Postpartum Women on Antiretroviral TherapyRisa M Hoffman, Meredith G Warshaw, K Rivet Amico, et al.
Antimicrobial Agents and Chemotherapy|October 26, 2023
Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026sMarije Van Schalkwyk, Adrie Bekker, Eric Decloedt, et al.
AIDS (London, England)|November 30, 2020
Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIVKristina M Brooks, Jeremiah D Momper, Mauricio Pinilla, et al.
Antimicrobial Agents and Chemotherapy|July 31, 2025
Pharmacokinetics of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum with and without efavirenz-based antiretroviral treatment: IMPAACT P1026s studyMarije Van Schalkwyk, Adrie Bekker, Eric Decloedt, et al.
The Journal of Infectious Diseases|June 5, 2024
Pharmacokinetics and Safety of Remdesivir in Pregnant and Nonpregnant Women With COVID-19: Results From IMPAACT 2032Kristina M Brooks, Kristin Baltrusaitis, Diana F Clarke, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 23, 2022
Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026sKristina M Brooks, Mauricio Pinilla, Alice M Stek, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 24, 2004
Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022Jane Hitti, Lisa M Frenkel, Alice M Stek, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 26, 2019
Predictors of Viremia in Postpartum Women on Antiretroviral TherapyRisa M Hoffman, Meredith G Warshaw, K Rivet Amico, et al.
Antimicrobial Agents and Chemotherapy|October 26, 2023
Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026sMarije Van Schalkwyk, Adrie Bekker, Eric Decloedt, et al.
AIDS (London, England)|November 30, 2020
Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIVKristina M Brooks, Jeremiah D Momper, Mauricio Pinilla, et al.
Antimicrobial Agents and Chemotherapy|July 31, 2025
Pharmacokinetics of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum with and without efavirenz-based antiretroviral treatment: IMPAACT P1026s studyMarije Van Schalkwyk, Adrie Bekker, Eric Decloedt, et al.
The Journal of Infectious Diseases|June 5, 2024
Pharmacokinetics and Safety of Remdesivir in Pregnant and Nonpregnant Women With COVID-19: Results From IMPAACT 2032Kristina M Brooks, Kristin Baltrusaitis, Diana F Clarke, et al.
Pageof 5